RxDoctor Payments Data

Michelle Hwang, MD

Otolaryngology · Charleston, SCNPI 1770945917

Payments from drug & device makers

$1,214in general payments, 2019–2025

Across 13 payments — averaging $93.41 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Checkpoint Surgical, Inc$339
  • Axogen$280
  • Johnson & Johnson$202
  • Kerecis Limited$121
  • Stryker$111
  • Boston Scientific$98
  • plus $64 from 3 others

What the payments were for

  • Food & beverage$1,214100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Checkpoint Surgical, Inc2$339
Axogen3$280
Johnson & Johnson2$202
Kerecis Limited1$121
Stryker1$111
Boston Scientific1$98
AbbVie1$25
Biocircuit Technologies Inc1$22
Ultragenyx Pharmaceutical Inc.1$18

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$1,214 in reported general payments places this provider in the 40th percentile of 180 otolaryngology providers in South Carolina.

See all otolaryngology providers in South Carolina

Medicare billing

Part B allowed, 2024
$87,932
Medicare patients
141
Services billed
2,820

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Fluticasone Propionate19$211

Paid to pharmacies, not to this prescriber.

Other otolaryngology in Charleston

See the full list for South Carolina

Where these figures come from

Is this you, or does something look wrong? →